BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 19786268)

  • 21. Mechanical dyssynchrony by 3D echo correlates with acute haemodynamic response to biventricular pacing in heart failure patients.
    van Dijk J; Knaapen P; Russel IK; Hendriks T; Allaart CP; de Cock CC; Kamp O
    Europace; 2008 Jan; 10(1):63-8. PubMed ID: 18065485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart rate and dyssynchrony in patients with cardiac resynchronization therapy: a pilot study.
    Naar J; Mortensen L; Winter R; Johnson J; Shahgaldi K; Manouras A; Braunschweig F; Ståhlberg M
    Scand Cardiovasc J; 2017 Jun; 51(3):143-152. PubMed ID: 28335644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of pacing site characteristics on response to cardiac resynchronization therapy.
    Wong JA; Yee R; Stirrat J; Scholl D; Krahn AD; Gula LJ; Skanes AC; Leong-Sit P; Klein GJ; McCarty D; Fine N; Goela A; Islam A; Thompson T; Drangova M; White JA
    Circ Cardiovasc Imaging; 2013 Jul; 6(4):542-50. PubMed ID: 23741053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position.
    Becker M; Zwicker C; Kaminski M; Napp A; Altiok E; Ocklenburg C; Friedman Z; Adam D; Schauerte P; Marx N; Hoffmann R
    JACC Cardiovasc Imaging; 2011 Apr; 4(4):366-74. PubMed ID: 21492811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders.
    Da Costa A; Thévenin J; Roche F; Faure E; Roméyer-Bouchard C; Messier M; Convert G; Barthélemy JC; Isaaz K
    Heart Rhythm; 2006 Apr; 3(4):406-13. PubMed ID: 16567286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Model-based navigation of left and right ventricular leads to optimal targets for cardiac resynchronization therapy: a single-center feasibility study.
    Laksman Z; Yee R; Stirrat J; Gula LJ; Skanes AC; Leong-Sit P; Manlucu J; McCarty D; Turkistani Y; Scholl D; Rajchl M; Goela A; Islam A; Thompson RT; Drangova M; White JA
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1040-7. PubMed ID: 25221334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measures of left ventricular dyssynchrony and the correlation to clinical and echocardiographic response after cardiac resynchronization therapy.
    Abdelhadi R; Adelstein E; Voigt A; Gorcsan J; Saba S
    Am J Cardiol; 2008 Sep; 102(5):598-601. PubMed ID: 18721519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectral pulsed-wave tissue Doppler imaging lateral-to-septal delay fails to predict clinical or echocardiographic outcome after cardiac resynchronization therapy.
    Soliman OI; Theuns DA; Geleijnse ML; Anwar AM; Nemes A; Caliskan K; Vletter WB; Jordaens LJ; Cate FJ
    Europace; 2007 Feb; 9(2):113-8. PubMed ID: 17218390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Right ventricular septal pacing as alternative for failed left ventricular lead implantation in cardiac resynchronization therapy candidates.
    Alhous MH; Small GR; Hannah A; Hillis GS; Frenneaux M; Broadhurst PA
    Europace; 2015 Jan; 17(1):94-100. PubMed ID: 25359384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bifocal pacing in the right ventricle: an alternative to resynchronization when left ventricular access is not possible in end-stage heart failure patients.
    Chudzik M; Piestrzeniewicz K; Klimczak A; Gawłowska J; Oszczygieł A; Wranicz JK; Bartczak K
    Cardiol J; 2010; 17(1):35-41. PubMed ID: 20104455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
    Rönn F; Kesek M; Karp K; Henein M; Jensen SM
    Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The right ventricular septum presents the optimum site for maximal electrical separation during left ventricular pacing.
    Miranda RI; Nault M; Simpson CS; Michael KA; Abdollah H; Baranchuk A; Redfearn DP
    J Cardiovasc Electrophysiol; 2012 Apr; 23(4):370-4. PubMed ID: 22049976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Larger interventricular conduction time enhances mechanical response to resynchronization therapy.
    Padeletti L; Pieragnoli P; Ricciardi G; Perrotta L; Perini AP; Grifoni G; Ricceri I; Padeletti M; Lionetti V; Valsecchi S
    Pacing Clin Electrophysiol; 2013 Apr; 36(4):416-23. PubMed ID: 23305325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy.
    Ypenburg C; van Bommel RJ; Delgado V; Mollema SA; Bleeker GB; Boersma E; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2008 Oct; 52(17):1402-9. PubMed ID: 18940531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
    Khan FZ; Virdee MS; Palmer CR; Pugh PJ; O'Halloran D; Elsik M; Read PA; Begley D; Fynn SP; Dutka DP
    J Am Coll Cardiol; 2012 Apr; 59(17):1509-18. PubMed ID: 22405632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of the longest intrapatient left ventricular electrical delay may predict acute hemodynamic improvement in patients after cardiac resynchronization therapy.
    Zanon F; Baracca E; Pastore G; Fraccaro C; Roncon L; Aggio S; Noventa F; Mazza A; Prinzen F
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):377-83. PubMed ID: 24668162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of LV lead position in cardiac resynchronization therapy using different imaging modalities.
    Becker M; Altiok E; Ocklenburg C; Krings R; Adams D; Lysansky M; Vogel B; Schauerte P; Knackstedt C; Hoffmann R
    JACC Cardiovasc Imaging; 2010 May; 3(5):472-81. PubMed ID: 20466342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of left ventricular pacing site on cardiac resynchronization therapy outcome and mortality: the results of a PROSPECT substudy.
    Mortensen PT; Herre JM; Chung ES; Bax JJ; Gerritse B; Kruijshoop M; Murillo J
    Europace; 2010 Dec; 12(12):1750-6. PubMed ID: 20852290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of left ventricular endocardial activation pattern on echocardiographic and clinical response to cardiac resynchronization therapy.
    Fung JW; Chan JY; Yip GW; Chan HC; Chan WW; Zhang Q; Yu CM
    Heart; 2007 Apr; 93(4):432-7. PubMed ID: 17237127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.